ClinicalTrials.gg
Not yet recruitingNCT07522138SelfExPDUpdated Apr 15, 2026

Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study

An interventional study of Home-based self-exercise feedback program using video in Home Exercise Program, PD - Parkinson's Disease and Feasibility Studies, sponsored by Seoul National University Hospital. Not yet recruiting at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Parkinson Disease by Seoul National University Hospital — 2 open to participants now, 2 under way, none of them phase 3. Parkinson Disease · Seoul National University Hospital.

Planned enrollment
19th of 21
15 · median 40
Started
2026
the only one that year
No phase
12 of 23
1 open now
Registered
23rd of 23
by date

Among the 23 studies in Parkinson Disease by Seoul National University Hospital, this one is the 19th largest by planned enrollment of the 21 interventional ones that give a count, is the only one that started in 2026, is one of 12 with no phase, and was the 23rd registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

2 of the 23 studies in Parkinson Disease by Seoul National University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Parkinson Disease by Seoul National University Hospital, or all of them as a file.
02

Study summary

This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.

03

Conditions studied

  • Home Exercise Program
  • PD - Parkinson's Disease
  • Feasibility Studies

Browse trials for

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 19 years or older, clinically diagnosed with Idiopathic Parkinson's Disease (PD) according to the Movement Disorder Society (MDS) clinical diagnostic criteria
  • Patients at Hoehn and Yahr stage 1-2.5
  • Patients on stable dopaminergic therapy with no changes in the past 1 month
  • Patients receiving Lee Silverman Voice Treatment (LSVT) rehabilitation therapy once weekly as outpatients
  • Patients who have voluntarily provided to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients diagnosed with atypical parkinsonism
  • Patients with musculoskeletal problems that make participation in rehabilitation difficult
  • Patients who have limited access to the video-based home exercise feedback program
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Home-based Exercise Program (Single Arm)

    Participants follow a 6-week home-based exercise program guided by instructional videos, including stretching, strength, balance, aerobic, and LSVT-specific exercises. A camera provides real-time feedback using the iPixel exercise feedback system, and participants complete sessions at least 5 times per week, 40 minutes per session, with weekly 30-minute in-person check-ins for monitoring and support.

    Behavioral: Home-based self-exercise feedback program using video

Interventions

  • BehavioralHome-based self-exercise feedback program using video

    Participants follow a 6-week home-based exercise program using video-guided instructions and the iPixel exercise feedback system, which monitors movements in real-time and provides corrective feedback. The program includes: Stretching exercises, Strength training, Balance exercises, Aerobic exercises, LSVT-specific exercises. Participants are instructed to complete sessions at least 5 times per week, 40 minutes per session. Additionally, weekly 30-minute in-person rehabilitation sessions are conducted to adjust the next week's exercise intensity based on each participant's functional level.

06

What researchers measure

Primary outcomes

  1. Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part III (Motor Examination)

    0 to 108, with higher scores indicating worse motor function.

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. Modified Hoehn and Yahr sacle

    Modified Hoehn and Yahr Scale Score range: 0 to 5, with higher scores indicating more severe disease stage.

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Berg Balance Scale

    0 to 56, with higher scores indicating better balance ability.

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. Functional Gait Ability

    0 to 30, with higher scores indicating better gait function.

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Freezing of Gait Questionnaire

    0 to 24, with higher scores indicating more severe freezing of gait.

    Time frame: From enrollment to the end of treatment at 6 weeks

  5. EuroQol-5 Dimention Questionnaire

    0 to 1, with higher scores indicating better health-related quality of life.

    Time frame: From enrollment to the end of treatment at 6 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Colon-Semenza C, Latham NK, Quintiliani LM, Ellis TD. Peer Coaching Through mHealth Targeting Physical Activity in People With Parkinson Disease: Feasibility Study. JMIR Mhealth Uhealth. 2018 Feb 15;6(2):e42. doi: 10.2196/mhealth.8074. PubMed 29449201 ↗
  • van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, Overeem S, Deeg DJ, Borm GF, van der Horst MH, Bloem BR, Munneke M. Physical inactivity in Parkinson's disease. J Neurol. 2011 Dec;258(12):2214-21. doi: 10.1007/s00415-011-6097-7. Epub 2011 May 26. PubMed 21614433 ↗
  • Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord. 2010 Aug 15;25(11):1646-51. doi: 10.1002/mds.23135. PubMed 20629164 ↗
  • Fox SH, Luca DG, Postuma RB, Bhidayasiri R, Cardoso F, Kovacs GG, Katzenschlager R, Trenkwalder C. Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases. NPJ Parkinsons Dis. 2025 Dec 13;11(1):360. doi: 10.1038/s41531-025-01206-6. PubMed 41390531 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Dec 2026, 7 months later.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 7 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 3, 2026
First posted
Apr 13, 2026
StartEst.
Apr 20, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Feb 28, 2027
Last update
Apr 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07522138
Responsible party
Won-Seok Kim (Professor, Seoul National University Bundang Hospital) — Principal investigator
First posted
Apr 13, 2026
Start date
Apr 20, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Apr 15, 2026

Study contacts

Won-Seok Kim, MD, PhD
Contact
wondol77@gmail.com
+82317877735
SunJeong Gwon, BS
Contact
otchoice@daum.net
+8210-2836-5937
Won-Seok Kim, MD, PhD
principal investigator · Seoul National University Bundang Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion